Podcast Episodes
Back to Search
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
Episode 9
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on MET exon 14 testing and selecti…
5 years, 7 months ago
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2
Episode 10
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on biomarking testing and the use …
5 years, 7 months ago
Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
Episode 7
In this episode, Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer questions focused on the topic of current and evolving use of im…
5 years, 7 months ago
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL
Episode 8
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meetin…
5 years, 7 months ago
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
Episode 6
In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly…
5 years, 8 months ago
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
Episode 5
In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor the…
5 years, 8 months ago
Improving Outcomes for Patients With CML With TKIs: FAQ Podcast
Episode 4
In this episode, Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer questions focused on the optimal …
5 years, 8 months ago
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions
Episode 1
In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overvie…
5 years, 8 months ago
Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies
Episode 2
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on biomarker testing and selecting targeted therap…
5 years, 8 months ago
Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors
Episode 3
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on current and evolving biomarkers for immune chec…
5 years, 8 months ago